Endocyte, Inc.

Melissa Nelson

Christopher Paul Leamon

Iontcho Radoslavov Vlahov

Joseph Anand Reddy

Marilynn Vetzel

Alicia Bloomfield

Ryan Dorton

Garth L Parham

Christina M Dircksen

The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.

Conjugates for treating diseases caused by PSMA expressing cells

The disclosure provided herein pertains to CCK2R-drug conjugates. In particular, the disclosure pertains to CCK2R-drug conjugates that target the delivery of drugs to a mammalian recipient. Also described are methods of making and using CCK2R-drug conjugates.

CCK2R-drug conjugates

Growing community of inventors

Delphi, IN, United States of America

Melissa Nelson